Research News and Research

RSS

European experts publish common vision of priorities for marine research

Some 340 European scientists, policy-makers and other experts representing 143 organizations from 31 countries spoke with one voice today, publishing a common vision of today's most pressing marine-related health and economic threats and opportunities.

9 Oct 2014

Antibiotic stewardship programs reduce length of stay and hospital readmission in children

Hospitalized children go home sooner and are less likely to be readmitted when the hospital has an antibiotic stewardship program that's dedicated to controlling antibiotic prescriptions and treatment, according to a study being presented at IDWeek 2014-. The study is the first to show the benefits of such programs on children's health.

9 Oct 2014

States grapple with Obamacare premium increases, related issues

In California, voters are split over a ballot initiative that would give the state's insurance commissioners new powers to veto health insurance cost increases. Meanwhile, in Iowa, the insurance commissioner approves rate increases proposed by three insurers.

9 Oct 2014

Researchers develop nanoparticle eye drops to combat dry eye syndrome

For the millions of sufferers of dry eye syndrome, their only recourse to easing the painful condition is to use drug-laced eye drops three times a day.

9 Oct 2014

Neuroscientists solve mystery of ‘chemo brain’

It is estimated that as many as half of patients taking cancer drugs experience a decrease in mental sharpness.

9 Oct 2014

New method can reduce environmental impact caused by manufacturing processes

The human and environmental dangers posed by a widely used manufacturing technique could be almost eradicated thanks to research led by Plymouth University.

9 Oct 2014

Gold Crest Care Center joins the cause to raise awareness for breast cancer

Gold Crest Care Center, one of the leading nursing homes in NYC, has joined the cause to raise awareness for breast cancer education, prevention and treatment. The Bronx, N.Y. facility is dedicated to providing top-notch care for all patients while providing educational services to clients and their families.

9 Oct 2014

GE Healthcare-Glaxo Smith Kline deal to create force in cancer testing

A recently announced deal between GE Healthcare-subsidiary Clarient and Glaxo Smith Kline will create a force in cancer testing, according to Kalorama Information. The healthcare market research publisher tracks companion products, and says that the two entities will form a multi-purpose, data analytics- and companion diagnostics-driven network of laboratories. Kalorama Information recently released a market study, Companion Diagnostics Market, for companion diagnostics such as the drug-test combinations envisioned in this deal.

9 Oct 2014

VAL-083 drug compound shows promise against non-small cell lung cancer

DelMar Pharmaceuticals, Inc., a clinical-stage oncology company, today announced the presentation of promising new data supporting the activity of its lead drug compound, VAL-083, in the treatment of non-small cell lung cancer (NSCLC) at the AACR's New Horizons in Cancer Research: Harnessing Breakthroughs – Targeting Cures. The conference takes place October 9th to 12th in Pudong, Shanghai.

9 Oct 2014

Isis Pharmaceuticals secures $18 million from GSK to advance ISIS-TTR Rx Phase 2/3 study

Isis Pharmaceuticals, Inc. announced today that it has earned an $18 million milestone payment from GlaxoSmithKline related to the advancement of the Phase 2/3 study of ISIS-TTRRx in patients with familial amyloid polyneuropathy (FAP).

9 Oct 2014

HerStory app helps women with breast cancer to share their voices with other patients

As physicians spend less time with their patients, often as little as 10-15 minutes per appointment, they grow increasingly wary of the limited emotional support they can provide within that time frame.

9 Oct 2014

Exposure to workplace violence can lead to serious consequences for health sector employees

Exposure to violence in the workplace can lead to serious consequences for health sector employees say Stéphane Guay and Nathalie Lanctôt of the Institut universitaire de santé mentale and the University of Montreal, who studied this issue in a systematic review of the literature.

9 Oct 2014

CytRx begins Phase 1b trial of aldoxorubicin plus gemcitabine in patients with metastatic solid tumors

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced the initiation of enrollment in an open-label Phase 1b clinical trial designed to investigate the preliminary safety and activity of aldoxorubicin plus gemcitabine in subjects with metastatic solid tumors.

9 Oct 2014

KNCV becomes prime partner for USAID's flagship tuberculosis program

KNCV Tuberculosis Foundation, the Dutch NGO specialized in the fight against tuberculosis, will be the prime partner for the United States Agency for International Development in their new five year flagship program 'Challenge TB'.

9 Oct 2014

Impax executes definitive agreement to acquire Tower Holdings, Lineage Therapeutics

Impax Laboratories, Inc. today announced the execution of a definitive agreement under which Impax will acquire Tower Holdings, Inc., including operating subsidiaries CorePharma LLC and Amedra Pharmaceuticals LLC, and Lineage Therapeutics Inc. (together, the "Companies") for $700 million in cash, subject to certain customary purchase price adjustments.

9 Oct 2014

Power grid failure inside injured cardiac cells triggers post-heart attack arrhythmias

Heart attack survivors often experience dangerous heart rhythm disturbances during treatment designed to restore blood flow to the injured heart muscle, a common and confounding complication of an otherwise lifesaving intervention.

9 Oct 2014

Study finds that skin exposure may trigger early peanut allergy in children

Many children may become allergic to peanuts before they first eat them, and skin exposure may be contribute to early sensitization, according to a study in mice led by Mount Sinai researchers and published today in the Journal of Clinical Investigation.

9 Oct 2014

Researchers are developing compounds to combat causative agents of periodontitis

A total 12 million Germans suffer from periodontitis. If the inflammation remains untreated, this could lead to tooth loss. However, it is also suspected of triggering many other diseases, like cardiopulmonary diseases. Researchers are studying the interactions, and developing compounds to combat the causative agents.

9 Oct 2014

Social status can impact health, happiness even among egalitarian forager-farmers

In western society, where keeping up with the Joneses — or, better yet, surpassing them — is expected and even encouraged, status matters. So important is it that for many people, physical and emotional wellbeing are directly connected to their place in the social hierarchy.

9 Oct 2014

University of Luxembourg researchers identify potential new ways to test colorectal cancer

Researchers at the University of Luxembourg have identified potential new ways to test for the first signs of one of the most deadly types of cancer: colorectal cancer. They have found new "biomarkers": molecules whose increased presence or absence in tissue suggests the development of tumorous cells. These indicators could help detect colorectal cancer at an early stage, predict its severity or even offer new treatments.

9 Oct 2014

Research News and Research

European experts publish common vision of priorities for marine research

Antibiotic stewardship programs reduce length of stay and hospital readmission in children

States grapple with Obamacare premium increases, related issues

Researchers develop nanoparticle eye drops to combat dry eye syndrome

Neuroscientists solve mystery of ‘chemo brain’

New method can reduce environmental impact caused by manufacturing processes

Gold Crest Care Center joins the cause to raise awareness for breast cancer

GE Healthcare-Glaxo Smith Kline deal to create force in cancer testing

VAL-083 drug compound shows promise against non-small cell lung cancer

Isis Pharmaceuticals secures $18 million from GSK to advance ISIS-TTR Rx Phase 2/3 study

HerStory app helps women with breast cancer to share their voices with other patients

Exposure to workplace violence can lead to serious consequences for health sector employees

CytRx begins Phase 1b trial of aldoxorubicin plus gemcitabine in patients with metastatic solid tumors

KNCV becomes prime partner for USAID's flagship tuberculosis program

Impax executes definitive agreement to acquire Tower Holdings, Lineage Therapeutics

Power grid failure inside injured cardiac cells triggers post-heart attack arrhythmias

Study finds that skin exposure may trigger early peanut allergy in children

Researchers are developing compounds to combat causative agents of periodontitis

Social status can impact health, happiness even among egalitarian forager-farmers

University of Luxembourg researchers identify potential new ways to test colorectal cancer

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy